Obesity and Metabolic Disorder

Obesity is an uncharacteristic or excessive body fat accretion. It is recognized by a body mass index (BMI) of 30 or higher. Metabolic syndrome is accompanying with the risk of developing cardiovascular disease and Type 2 diabetes. Insulin conflict, metabolic disease, and pre-diabetes are closely interconnected to one another and have overlapping aspects. The syndrome is thought to be caused by an underlying disorder of energy exploitation and storage. The source of the syndrome is an area of on-going medical research. Complications triggered comprise cardiovascular disorders (particularly in people with excess abdominal fat), diabetes mellitus, assured cancers, cholelithiasis, fatty liver, cirrhosis, osteoarthritis, reproductive syndromes in men and women, psychological disorders, and, for people with BMI ≥ 35, premature death.

 

 

  • Sarcopenic Obesity
  • Lipid Control in Diabetes and Metabolic Syndrome
  • Quantitative trait and Obesity
  • Obstructive Sleep Apnea
  • Metabolic Bone Disease

Related Conference of Obesity and Metabolic Disorder

March 07-08, 2024

14th World Glycobiology Congress

Toronto, Canada
March 07-08, 2024

30th Asia Pacific Biotechnology Congress

Dubai, UAE
March 28-29, 2024

6th International Conference on Biochemistry

Dubai, UAE
September 25-26, 2024

20th World Congress on Structural Biology

Paris, France
October 03-04, 2024

15th International Conference on Biofuels and Bioenergy

Singapore City, Singapore

Obesity and Metabolic Disorder Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in